To confirm that CYP46A1 expression is reduced in GBMs at the protein level, we performed IHC staining for CYP46A1 on an independent cohort of glioma (n = 58) and normal brain tissue samples (n = 6). This evidence concerns the gene CYP46A1 and glioma.